Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Safety and Efficacy of IV Infusion of TZP-101 for POI After Major Open Abdominal Surgery

ClinicalTrials.gov ID: NCT00617552

Public ClinicalTrials.gov record NCT00617552. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 12:06 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess Efficacy and Safety of TZP-101 When Administered as 30 Minute i.v. Infusion for POI to Subjects Undergoing Major Open Abdominal Surgery

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine whether TZP-101 is effective in the management of post operative ileus in subjects undergoing major open abdominal surgery (i.e. partial large bowel resection).

Study identification

NCT ID
NCT00617552
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Tranzyme, Inc.
Industry
Enrollment
267 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2007 (Type not available)
Primary completion
Jul 2008 (Actual)
Completion
Aug 2008 (Actual)
Last update posted
Dec 7, 2012

2007 – 2008

United States locations

U.S. sites
10
U.S. states
9
U.S. cities
10
Facility City State ZIP Site status
Office of Dr. Phillip Fleshner Los Angeles California 90048 —
University of Miami Clinic Miami Florida 33136 —
Renstar Medical Research Ocala Florida 34471 —
Northwestern University Chicago Illinois 60611 —
Univ. of Maryland, R.A. Cowley Shock Trauma Center Baltimore Maryland 21201 —
Baystate Medical Center/Baystate Health Springfield Massachusetts 01199 —
Michigan State/Spectrum Health Grand Rapids Michigan 49503 —
Stony Brook University Hospital Stony Brook New York 11794 —
Mid Dakota Clinic, PC Bismarck North Dakota 58501 —
The Methodist Hospital Houston Texas 77030 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00617552, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 7, 2012 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00617552 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →